Additionally, those with severe inflammatory bowel disease (Crohn's disease or ulcerative colitis) may experience worsening diarrhea, nausea, or abdominal cramping, since GLP-1 agonists already cause gastrointestinal side effects in 3050% of users
Statins are the first line treatment for reducing cholesterol
Cysteine supplementation reverses methionine restriction effects on rat adiposity: significance of stearoyl-coenzyme A desaturase
Alharbi K, Al-Osaimi AA, Alghamdi BA (2022) Sodium chloride (NaCl)-induced physiological alteration and oxidative stress generation in Pisum sativum (L.): a toxicity assessment
Dihexa is proposed to act as an HGF mimetic, amplifying c-Met receptor activation
Scientists don't fully understand how these drugs work yet